Acadia Pharmaceuticals reported $0 in Loan Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Alexion Pharmaceuticals ALXN:US $ 2388.8M 30.8M
ALKERMES ALKS:US 294.07M 632K
Alnylam Pharmaceuticals ALNY:US $ 433.15M 241.56M
Aptinyx Inc APTX:US $ 0 0
Arena Pharmaceuticals ARNA:US $ 38.78M 1.25M
Biogen BIIB:US $ 6272.3M 996.9M
Biomarin Pharmaceutical BMRN:US $ 1077.11M 0.98M
Bristol Myers Squibb BMY:US $ 42503M 2002M
Cara Therapeutics CARA:US $ 0 0
Corcept Therapeutics CORT:US $ 0M 0M
Cytokinetics CYTK:US $ 127.89M 3.88M
Eisai 4523:JP Y 49913M 5M
Eli Lilly And LLY:US $ 14736.6M 1463M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Intercept Pharmaceuticals ICPT:US $ 575.82M 7.7M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Moderna Inc MRNA:US $ 328M 190M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Prothena PRTA:US 0 0
Ptc Therapeutics PTCT:US $ 1115.38M 3.45M
Sarepta Therapeutics SRPT:US $ 1092.98M 1.88M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vanda Pharmaceuticals VNDA:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 524.92M 5.4M
YTE INCY:US $ 31.84M 0.32M
Zogenix ZGNX:US $ 153.63M 2.18M